Matthew A. Firth

1.6k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Matthew A. Firth is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Matthew A. Firth has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Infectious Diseases. Recurrent topics in Matthew A. Firth's work include T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Matthew A. Firth is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Matthew A. Firth collaborates with scholars based in Canada, United States and Australia. Matthew A. Firth's co-authors include Joseph C. Sun, Georg Gasteiger, Sharline Madera, Douglas C. Hodgins, Patricia E. Shewen, Lewis L. Lanier, Joshua Beilke, Moritz Rapp, Meera Bhat and Morgan Huse and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Cancer Cell.

In The Last Decade

Matthew A. Firth

16 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of Zoonotic Pathogens and Characterization of Novel Viruses Carried by Commensal Rattus norvegicus in New York City

2014 296 citations Cadhla Firth, Meera Bhat et al. mBio profile →

Peers

Countries citing papers authored by Matthew A. Firth

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Firth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Firth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Firth more than expected).

Fields of papers citing papers by Matthew A. Firth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Firth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Firth. The network helps show where Matthew A. Firth may publish in the future.

Co-authorship network of co-authors of Matthew A. Firth

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Firth. A scholar is included among the top collaborators of Matthew A. Firth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Firth. Matthew A. Firth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide 2016 ·The Journal of Experimental Medicine ·Sharline Madera, Moritz Rapp, Matthew A. Firth, Joshua Beilke, Lewis L. Lanier, Joseph C. Sun	154
2	Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia 2016 ·Cancer Cell ·Margherita Ghisi, Lev M. Kats, Frédérick Masson, Jason Li, Tobias Kratina, Eva Vidacs, Omer Gilan, Maria Doyle, Andrea Newbold, Jessica E. Bolden, Kirsten A. Fairfax, Carolyn A. de Graaf, Matthew A. Firth, Johannes Zuber, Ross A. Dickins, Lynn M. Corcoran, Mark A. Dawson, Gabrielle T. Belz, Ricky W. Johnstone	26
3	Preliminary Survey of Ectoparasites and Associated Pathogens from Norway Rats in New York City 2015 ·Journal of Medical Entomology ·Matthew Frye, Cadhla Firth, Meera Bhat, Matthew A. Firth, Xiaoyu Che, (unknown), Simon H. Williams, W. Ian Lipkin	33
4	Detection of Zoonotic Pathogens and Characterization of Novel Viruses Carried by Commensal Rattus norvegicus in New York City breakdown → 2014 ·mBio ·Cadhla Firth, Meera Bhat, Matthew A. Firth, Simon H. Williams, Matthew Frye, Peter Simmonds, (unknown), James Ng, (unknown), Nishit Bhuva, Bohyun Lee, Xiaoyu Che, Phenix‐Lan Quan, W. Ian Lipkin	296
5	Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens 2014 ·The Journal of Experimental Medicine ·Theresa L. Geiger, Michael C. Abt, Georg Gasteiger, Matthew A. Firth, Margaret O'Connor, Clair D. Geary, Timothy E. O’Sullivan, Marcel R.M. van den Brink, Eric G. Pamer, Alan M. Hanash, Joseph C. Sun	202
6	Nfil3-independent lineage maintenance and antiviral response of natural killer cells 2013 ·The Journal of Experimental Medicine ·Matthew A. Firth, Sharline Madera, Aimee M. Beaulieu, Georg Gasteiger, Eliseo F. Castillo, Kimberly S. Schluns, Masato Kubo, Paul B. Rothman, Éric Vivier, Joseph C. Sun	119
7	IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells 2013 ·The Journal of Experimental Medicine ·Georg Gasteiger, Saskia Hemmers, Matthew A. Firth, Audrey Le Floc’h, Morgan Huse, Joseph C. Sun, Alexander Y. Rudensky	168
8	Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle 2012 ·Developmental & Comparative Immunology ·Eric S. Pringle, Matthew A. Firth, Kuldeep S. Chattha, Douglas C. Hodgins, Patricia E. Shewen	2
9	Protein Kinase C-θ Clustering at Immunological Synapses Amplifies Effector Responses in NK Cells 2012 ·The Journal of Immunology ·Ernesto Merino, Thushara P. Abeyweera, Matthew A. Firth, Carolyn L. Zawislak, Roshni Basu, Xin Liu, Joseph C. Sun, Morgan Huse	8
10	Incorporation of antigens from Mannheimia haemolytica culture supernatant, and recombinant bovine C3d into ISCOM matrix using neutravidin–biotin interaction 2011 ·Biotechnology and Applied Biochemistry ·D.P. Moore, Douglas C. Hodgins, Matthew A. Firth, (unknown), P E Shewen	2
11	Expression of complement receptor 2 (CD21), membrane IgM and the inhibitory receptor CD32 (FcγRIIb) in the lymphoid tissues of neonatal calves 2010 ·Veterinary Immunology and Immunopathology ·Kuldeep S. Chattha, Matthew A. Firth, Douglas C. Hodgins, Patricia E. Shewen	10
12	Variation in expression of membrane IgM, CD21 (CR2) and CD32 (Fcγ RIIB) on bovine lymphocytes with age: A longitudinal study 2009 ·Developmental & Comparative Immunology ·Kuldeep S. Chattha, Matthew A. Firth, Douglas C. Hodgins, Patricia E. Shewen	16
13	Multiple bovine FcγRIIb sub-isoforms generated by alternative splicing 2009 ·Veterinary Immunology and Immunopathology ·Matthew A. Firth, Kuldeep S. Chattha, Douglas C. Hodgins, Patricia E. Shewen	5
14	Age related variation in expression of CD21 and CD32 on bovine lymphocytes: A cross-sectional study 2009 ·Veterinary Immunology and Immunopathology ·Kuldeep S. Chattha, Matthew A. Firth, Douglas C. Hodgins, Patricia E. Shewen	22
15	Cloning of a gene fragment encoding bovine complement component C3d with expression and characterization of derived fusion proteins 2006 ·Veterinary Immunology and Immunopathology ·Matthew A. Firth, (unknown), Yanlong Pei, Patricia E. Shewen, Reggie Y.C. Lo, Dongwan Yoo, Douglas C. Hodgins	5
16	Passive and active components of neonatal innate immune defenses 2005 ·Animal Health Research Reviews ·Matthew A. Firth, Patricia E. Shewen, Douglas C. Hodgins	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact